LncRNA15691 promotes T-ALL infiltration by upregulating CCR9 via increased MATR3 stability. Issue 2 (16th January 2023)

• Record Type: Journal Article
• Authors: Zeng, Xingruo; Lei, Yufei; Pan, Shan; Sun, Jiaxing; He, Hengjing; Xiao, Di; Jamal, Muhammad; Shen, Hui; Zhou, Fuling; Shao, Liang; Zhang, Quiping
• Is Part Of: Journal of leukocyte biology. Volume 113:Issue 2(2023)
• Page Start: 203
• Page End: 215
• Publication Date: 2023-01-16
• Subjects: leukemia -- chemokine receptor -- long noncoding RNAs -- extramedullary infiltration -- RNA-binding proteins; Leucocytes -- Periodicals; Reticulo-endothelial system -- Periodicals; 571.96
• DOI: 10.1093/jleuko/qiac010
• Languages: English
• ISSNs: 0741-5400

Abstract

Abstract: Our previous studies demonstrated that CCR9 plays an important role in several aspects of T-cell acute lymphoblastic leukemia progression and that CCR9 is a potential therapeutic target. However, the underlying mechanism that regulates CCR9 expression remains incompletely understood. In this study, bioinformatics analysis and validation in clinical samples revealed the lncRNA15691 to be positively correlated with CCR9 mRNA expression and significantly upregulated in T-cell acute lymphoblastic leukemia samples and CCR9 high T-cell acute lymphoblastic leukemia cell lines. LncRNA15691, a previously uncharacterized lncRNA, was found to be located in both the cytoplasm and the nucleus via fluorescence in situ hybridization assay. In addition, lncRNA15691 upregulated the expression of CCR9 and was involved in T-cell acute lymphoblastic leukemia cell invasion. In vivo experiments showed that lncRNA15691 promoted leukemia cell homing/infiltration into the bone marrow, blood, and spleen, whereas the CCR9 ligand, CCL25, augmented the extramedullary infiltration of CCR9 low leukemia cells overexpressing lncRNA15691 into blood, spleen, and liver. Subsequently, RNA protein pull-down assays, coupled with liquid chromatography–tandem mass spectrometry, were used to uncover potential lncRNA15691-interacting proteins, which were then validated by RNA immunoprecipitation. These mechanistic studies revealed that lncRNA15691 upregulated CCR9 expression via directly binding to and stabilizing MATR3 by inhibiting its nuclear degradation mediated by PKA. Collectively, our study revealed a novel mechanism of regulating CCR9 expression and implicated lncRNA15691 as a potential novel biomarker for T-cell acute lymphoblastic leukemia infiltration. Abstract : LncRNA15691 upregulates CCR9 expression and promotes T-cell acute lymphoblastic leukemia infiltration via directly binding to and stabilizing MATR3 by inhibiting its nuclear degradation mediated by PKA.